Purdue Pharma L.P. ( Purdue Pharma)

Primary tabs

Purdue Pharma's picture

Management

Contact Address

About Purdue Pharma L.P.

Purdue Pharma L.P. is a privately-held pharmaceutical company headquartered in Stamford, Conn. Purdue Pharma is part of a network of independent associated companies dedicated to providing patients and providers with innovative medicines.

Purdue Pharma press release, blog etc

Sat, 06/21/2025 - 03:43 Purdue Pharma L.P. Receives Court Approval of Disclosure Statement Filed in Connection with its Plan of Reorganization
Wed, 03/19/2025 - 01:19 Purdue Pharma L.P. Files New Plan of Reorganization Providing for More Than $7.4 Billion in Creditor Distributions
Wed, 03/23/2022 - 11:01 Harm Reduction Therapeutics to Receive Additional Funding for the Development of its Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma after Bankruptcy Court Approval
Fri, 12/17/2021 - 03:17 Purdue Pharma Statement with Respect to District Court Decision Vacating Bankruptcy Courts Confirmation of the Plan of Reorganization
Thu, 09/02/2021 - 20:17 Confirmed Plan of Reorganization Facilitates Creation of New Company Knoa Pharma
Tue, 07/27/2021 - 11:42 Creditors overwhelmingly support confirmation of the Plan
Mon, 05/03/2021 - 01:11 Purdue Pharma L.P. to Begin Soliciting Votes for its Broadly Supported Chapter 11 Plan of Reorganization
Mon, 03/01/2021 - 06:40 Former Montana Governor Steve Bullock to Monitor Purdues Compliance With Voluntary Injunction
Wed, 10/21/2020 - 09:47 Purdue Pharma Reaches Agreement With U.S. Department of Justice
Tue, 06/23/2020 - 09:23 Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.s Development of Over-the-Counter Opioid Overdose Reversal Medication
Fri, 02/21/2020 - 18:44 Purdue Taps Tom Vilsack, former Cabinet Secretary and Governor, to Monitor Compliance With Voluntary Injunction
Mon, 09/16/2019 - 08:30 Purdue Pharma Announces Agreement in Principle on Landmark Opioid Litigation Settlement
Tue, 08/20/2019 - 05:19 The Prescription Drug Safety Network Significantly Expands Its Reach in Year 2 and Reports an Average 48% Knowledge Gain Nationwide
Thu, 08/15/2019 - 13:25 Purdue Pharma L.P. and the National Center for Wellness & Recovery at Oklahoma State University Announce Collaboration Around Research to Address the Opioid Addiction Crisis
Tue, 07/02/2019 - 08:30 Julie Ducharme, BPharm, MSc, PhD Named Vice President and Chief Scientific Officer of Purdue Pharma L.P.
Tue, 06/18/2019 - 06:34 Purdue Pharma Presents Considerations in Opioid Comparator Selection at the College on Problems of Drug Dependence Annual Scientific Meeting
Thu, 06/06/2019 - 19:06 Purdue Pharma Announces First Participant Enrolled in Clinical Study Assessing Nalmefene HCl Injection for the Emergency Treatment of Known or Suspected Opioid Overdose
Mon, 04/29/2019 - 22:14 Eisai and Purdue Pharma Announce Buy Out of Purdues Rights in Worldwide Collaboration to Develop and Commercialize Lemborexant
more

InfoBox

HomePagewww.purduepharma.com
Twittertwitter.com/purduepharma
LinkedInwww.linkedin.com/company/purdue-pharma
Wikipediaen.wikipedia.org/wiki/Purdue_Pharma